AstraZeneca (AZN) Slides to $190 as Abivax Rumors, Oncology Expansion and Tezspire Growth Shape Investor Outlook
AstraZeneca PLC (AZN) slipped during the latest trading session, with shares trading around $190.49, down approximately 1.04%. The stock briefly rallied toward the $193 level earlier in the session before…







